Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Integrin antagonists for transplant immunosuppression: panacea or peril?

× No keyword cloud information.

20 in total

1. CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely.

Authors: Matthias Corbascio; Helene Ekstrand; Cecilia Osterholm; Zhongquan Qi; Mecislovas Simanaitis; Christian P Larsen; Thomas C Pearson; Kristian Riesbeck; Henrik Ekberg
Journal: Transpl Immunol Date: 2002-06 Impact factor: 1.708

Review 2. Integrins as therapeutic targets: lessons and opportunities.

Authors: Dermot Cox; Marian Brennan; Niamh Moran
Journal: Nat Rev Drug Discov Date: 2010-10 Impact factor: 84.694

3. LFA-1-specific therapy prolongs allograft survival in rhesus macaques.

Authors: Idelberto R Badell; Maria C Russell; Peter W Thompson; Alexandra P Turner; Tim A Weaver; Jennifer M Robertson; Jose G Avila; Jose A Cano; Brandi E Johnson; Mingqing Song; Frank V Leopardi; Sarah Swygert; Elizabeth A Strobert; Mandy L Ford; Allan D Kirk; Christian P Larsen
Journal: J Clin Invest Date: 2010-11-22 Impact factor: 14.808

4. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations.

Authors: M Hourmant; J Bedrossian; D Durand; Y Lebranchu; E Renoult; P Caudrelier; R Buffet; J P Soulillou
Journal: Transplantation Date: 1996-12-15 Impact factor: 4.939

5. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.

Authors: A M Posselt; M D Bellin; M Tavakol; G L Szot; L A Frassetto; U Masharani; R K Kerlan; L Fong; F G Vincenti; B J Hering; J A Bluestone; P G Stock
Journal: Am J Transplant Date: 2010-08 Impact factor: 8.086

6. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.

Authors: N A Turgeon; J G Avila; J A Cano; J J Hutchinson; I R Badell; A J Page; A B Adams; M H Sears; P H Bowen; A D Kirk; T C Pearson; C P Larsen
Journal: Am J Transplant Date: 2010-09 Impact factor: 8.086

7. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

Authors: F Vincenti; B Charpentier; Y Vanrenterghem; L Rostaing; B Bresnahan; P Darji; P Massari; G A Mondragon-Ramirez; M Agarwal; G Di Russo; C-S Lin; P Garg; C P Larsen
Journal: Am J Transplant Date: 2010-03 Impact factor: 8.086

8. Prolongation of islet allograft survival with an antibody to vascular cell adhesion molecule 1.

Authors: M D Stegall; A Ostrowska; J Haynes; F Karrer; I Kam; R G Gill
Journal: Surgery Date: 1995-08 Impact factor: 3.982

9. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts.

Authors: S Molossi; M Elices; T Arrhenius; R Diaz; C Coulber; M Rabinovitch
Journal: J Clin Invest Date: 1995-06 Impact factor: 14.808

10. Short-term administrations of a combination of anti-LFA-1 and anti-CD154 monoclonal antibodies induce tolerance to neonatal porcine islet xenografts in mice.

Authors: Hossein Arefanian; Eric B Tredget; Ray V Rajotte; Ron G Gill; Gregory S Korbutt; Gina R Rayat
Journal: Diabetes Date: 2010-01-19 Impact factor: 9.461

10 in total

1. Combined costimulatory and leukocyte functional antigen-1 blockade prevents transplant rejection mediated by heterologous immune memory alloresponses.

Authors: William H Kitchens; Divya Haridas; Maylene E Wagener; Mingqing Song; Mandy L Ford
Journal: Transplantation Date: 2012-05-27 Impact factor: 4.939

Review 2. The impact of infection and tissue damage in solid-organ transplantation.

Authors: Anita S Chong; Maria-Luisa Alegre
Journal: Nat Rev Immunol Date: 2012-05-25 Impact factor: 53.106

3. Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.

Authors: Danya Liu; I Raul Badell; Mandy L Ford
Journal: JCI Insight Date: 2018-01-11

Review 4. Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.

Authors: Leslie S Kean; Laurence A Turka; Bruce R Blazar
Journal: Immunol Rev Date: 2017-03 Impact factor: 12.988

10. Transient combination therapy targeting the immune synapse abrogates T cell responses and prolongs allograft survival in mice.

Authors: Paul M Schroder; Mithun Khattar; Ronghai Deng; Aini Xie; Wenhao Chen; Stanislaw M Stepkowski
Journal: PLoS One Date: 2013-07-24 Impact factor: 3.240